This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Should You Invest in the iShares U.S. Regional Banks ETF (IAT)?
by Zacks Equity Research
Sector ETF report for IAT
Should You Invest in the SPDR S&P Regional Banking ETF (KRE)?
by Zacks Equity Research
Sector ETF report for KRE
5 Banking ETFs That Outperformed Wall Street in January
by Sweta Jaiswal, FRM
Let's take a look at some banking ETFs that have outperformed the market in January.
U.S. Regional Banks ETF (IAT) Hits a 52-Week High
by Sweta Jaiswal, FRM
The iShares U.S. Regional Banks ETF (IAT) hits a new 52-week high. Are more gains in store?
Is SPDR S&P Regional Banking ETF (KRE) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for KRE
Fed Rate Hike in the Cards: Banking ETFs Likely to Gain
by Sweta Jaiswal, FRM
Let's consider some banking ETFs that can be great investment options amid the current U.S. economic conditions and increased possibility of an interest rate hike in March.
Count on Bank ETFs as Rates Rise
by Sweta Killa
A rising rate environment is highly beneficial for the financial sector, especially banks.
Should You Invest in the iShares U.S. Regional Banks ETF (IAT)?
by Zacks Equity Research
Sector ETF report for IAT
Should You Invest in the SPDR S&P Regional Banking ETF (KRE)?
by Zacks Equity Research
Sector ETF report for KRE
Should You Invest in the SPDR S&P Regional Banking ETF (KRE)?
by Zacks Equity Research
Sector ETF report for KRE
Should You Invest in the iShares U.S. Regional Banks ETF (IAT)?
by Zacks Equity Research
Sector ETF report for IAT
Financial ETFs at a 52-Week High: Further Rally Looks Likely
by Sanghamitra Saha
The vaccine drive, the return of global growth and the resultant inflationary pressure, rising oil demand and consumers' savings on fiscal and monetary stimulus have made the space a winner this year.
Financial ETFs Scaling New Highs: Here's Why
by Sweta Killa
The financial sector has been soaring lately on rising yields with many stocks and ETFs hitting new highs.
Fed Taper to Start in November? 7 ETFs to Buy
by Sanghamitra Saha
The Fed may start tapering in November. These ETFs could prove to be winning picks.
ECB Trims Support, Will Fed Follow Suit? ETFs in Focus
by Sanghamitra Saha
The European Central Bank (ECB) will slow down emergency bond purchases over the coming quarter.
Here's Why Banking ETFs Are Attractive Investment Bets
by Sweta Jaiswal, FRM
Let's consider some banking ETFs that can be great investment options amid the current U.S. economic conditions.
Is Taper-Tantrum Looming Ahead? 6 ETF Plays
by Sanghamitra Saha
Though the U.S. labor market is yet to improve, high inflation may lead the Fed go for a QE tapering. If it happens, these ETFs may gain ahead.
5 Top Performing Banking ETFs in 1H21
by Sweta Jaiswal, FRM
Let's take a look at some top-ranked banking ETFs that have gained more than 28% so far in the year.
Top-Ranked Banking ETFs to Bet on Now
by Sweta Jaiswal, FRM
Let's consider some top-ranked banking ETFs that can benefit from U.S. economic recovery.
Taper Talks to Start Soon? ETFs to Win
by Sanghamitra Saha
Federal Reserve officials showed cautious optimism about U.S. economic recovery. This along with rising inflation has triggered the talks of QE taper.
5 Banking ETFs That Have Gained More Than 30% YTD
by Sweta Jaiswal, FRM
Let's take a look at some banking ETFs that have gained more than 30% so far in the year.
Bank ETFs Tumble on Archegos Downfall: What's in Store?
by Sweta Killa
Despite the slide, the outlook for the banking industry looks promising given surging yields and an improving economy.
4 Sectors & Their ETFs Offering Great Value Now
by Sanghamitra Saha
Wall Street has rallied nicely this year on vaccine and fiscal stimulus optimism. But gains have mainly been supported by value stocks.
Will March See a 'Taper-Tantrum'-Like Crisis? 6 ETF Plays
by Sanghamitra Saha
February was really volatile for Wall Street due to rising rate worries. It reminded us of 2013's taper-tantrum. Will we see the same in March? If yes, you can prepare your portfolio with these ETFs.
How to Trade USFDA's EUA to J&J Vaccine With ETFs
by Sanghamitra Saha
On Feb 27, the United States sanctioned Johnson & Johnson's COVID-19 vaccine for emergency use, giving the nation a third vaccine to fight the outbreak, after BioNTech/Pfizer and Moderna.